期刊文献+

非高密度脂蛋白胆固醇的研究进展 被引量:4

The investigation of non-high density lipoprotein-cholesterol
下载PDF
导出
摘要 动脉粥样硬化(atherosclerosis,AS)是一类多因素性疾病,目前已经明确危险因素有血脂异常、高血压、血糖异常、吸烟和肥胖等。在所有这些危险因素中,低密度脂蛋白(low density lipoprotein,LDL)是致动脉粥样硬化的基本因素。动脉粥样硬化的发生是致病因素和保护因素相互消长的结果,致病因素的增强和(或)保护因素的减弱都会导致疾病的发生。
出处 《中国心血管病研究》 CAS 2010年第8期602-606,共5页 Chinese Journal of Cardiovascular Research
关键词 非高密度脂蛋白胆固醇 动脉粥样硬化 Non-high density lipoprotein-cholesterol Atherosclerosis
  • 相关文献

参考文献18

  • 1赵水平.血脂与动脉粥样硬化及其干预新动向[J].中国动脉硬化杂志,2009,17(3):169-171. 被引量:43
  • 2Brunzell JD,Davidson M,Furberg CD.Lipoprotein management in patients with cardiometabolic risk.Consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.JACC,2008,51:1512-1524.
  • 3Chouinard JA,Khalil A,Vermette P.Method of imaging low density lipoproteins by atomic force microscopy.Microsc Res Tech,2007,70:904-907.
  • 4Austin MA,Breslow JL,Hennekens CH,et al.Low-density lipoprotein subclass patterns and risk of myocardial infarction.JAMA,1988,260:1917-1921.
  • 5汪俊军,张春妮,庄一义.低密度脂蛋白亚组分不同特性在动脉粥样硬化中的作用[J].中国动脉硬化杂志,2004,12(2):227-228. 被引量:15
  • 6王绿娅,蔺洁,秦彦文,杜兰平,潘晓冬,石凤茹,顾云,赵庆.小颗粒致密低密度脂蛋白氧化特性及对血管内皮细胞脂质过氧化的影响[J].中国动脉硬化杂志,2003,11(4):309-313. 被引量:10
  • 7Baldi S,Frascerra s,Ferrannini E,et al.LDL resistance to oxidation:effects of lipid phenotype,autologous HDL and alanine.Clin Chim Acta,2007,379:95-100.
  • 8Lamarche B,St-Pierre AC,Ruel IL,et al.A prospective,population-based study of low density lopoprotein particles size as a risk factor for ischemic heart disease in men.Can J Cardiol,2001,17:859-865.
  • 9Koba S,Hirano T,Sakaue T,et al.Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels.J Cardiol,2000,36:371-378.
  • 10Hiltunen TP,Luoma JS,Nikkari T,et al.Expression of LDL receptor,VLDL receptor,LDL receptor-related protein,and scavenger receptor in rabbit atherosclerotic lesions:marked induction of scavenger receptor and VLDL receptor expression during lesion development.Circulation,1998,97:1079-1086.

二级参考文献56

  • 1汪俊军 孙翠平 等.糖尿病患者低密度脂蛋白中甘油三酯异常特征[J].南京大学学报,1996,32:58-58.
  • 2张娟综述 王绿娅 王拥军审校.氧化型低密度脂蛋白和动脉粥样硬化[J].中国动脉硬化杂志,2002,39(1):60-64.
  • 3王绿娅.三酰甘油与动脉粥样硬化[A].叶平.血脂的基础与临床[C].北京:人民军医出版社,2002.264-278.
  • 4王绿娅.动脉粥样硬化的病理生理机制[A].吴兆苏.心血管流行病学与人群防治[C].北京:人民卫生出版社,2002.131-136.
  • 5Tabas I, Williams K J, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerasis: update and therapeutic implications [ J ]. Circulcaion, 2007, 116 ( 16 ) :1 832-844.
  • 6Steinberg D, Glass CK, Witztum JL. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia [ J ]. Circulation, 2008, 118 (6) : 672-677.
  • 7Rodenburg J, Vissers MN, Wiegman A, et al. Statin treatment in children with familial hypercbelesterolemia: the younger, the better [ J ]. Circtdation, 2007, 116 (6) : 664 - 668.
  • 8Schunkert H, Samani NJU. Elevated C-reactive protein in atherosclerosischicken or egg [J]? N Engl J Med, 2008, 359 (1): 1 953-955.
  • 9Grundy SM, Gleeman Jl, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines[J]. Circulation, 2004, 110 (2) : 227 - 239.
  • 10Robinson JG. Models for describing relations among the various statin drugs, low-desity lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk [J]. Am J Cardiol, 2008, 101 (7) : 1 009-015.

共引文献108

同被引文献56

  • 1李健斋,王抒,曾平.非高密度脂蛋白胆固醇用于评估及预测冠心病危险[J].中华心血管病杂志,2004,32(11):963-966. 被引量:45
  • 2陈丹,陈燕,曾彩虹,刘志红,黎磊石.肾小球疾病患者肾间质泡沫细胞的分布及其临床意义[J].肾脏病与透析肾移植杂志,2006,15(4):322-328. 被引量:5
  • 3郭纪群,贾恩志,杨志健.吸烟与冠状动脉粥样硬化程度关系的研究[J].南京医科大学学报(自然科学版),2007,27(10):1187-1192. 被引量:16
  • 4Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aor- tic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well functioning older adults. Circula- tion, 2005,111 : 3384-3390.
  • 5Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiog- raphy. J Am Soc Eehocardiogr, 1989,2: 358-367.
  • 6Cosson S, Kevorkian JP. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes Metab,2003,29 : 455-466.
  • 7Schillaci G, Pasqualini L, Verdecchia P, et al. Prognostic sig- nificance of left ventricular diastolic dysfunction in essential hy- pertension. J Am Coil Cardiol,2002,39:2005-2011.
  • 8The Task Force for the management of dyslipidaemias of the Euro- pean Society of Cardiology (ESC) and the European Atherosclero- sis Society (EAS). 2011 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J,2011,32:1769-1818.
  • 9Wang XS, Paigen B. Genetics of variation in HDL cholesterol in humans and mice. Cire Res, 2005,96 : 27-42.
  • 10Packard CJ, Saito Y. non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb, 2004,11 : 6-14.

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部